Unilever PLC ULVR.L
Composite 51/100; the shares have moved about 26% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 24/100 — a strong mark against it.
Quality ranks 70/100 — a moderate point in its favour. Income ranks 67/100 — a moderate point in its favour. Valuation ranks 56/100 — a slight point in its favour.
Growth ranks 24/100 — a strong mark against it. Momentum ranks 42/100 — a slight mark against it. Balance-sheet strength ranks 44/100 — a slight mark against it.
What the company does Unilever PLC is a global fast-moving consumer goods company with four segments: Beauty & Wellbeing (hair/skin care), Personal Care (soap, deodorant, oral care), Home Care (laundry/cleaning), and Foods (condiments, bouillons, meal solutions). Its portfolio includes brands like Dove, Knorr, Hellmann’s, and Rexona.
Key financials Unilever’s profitability metrics are strong: ROE 31.9%, ROA 8.4%, ROCE 38.1%, and gross/operating/net margins of 47.1%/19.4%/18.3%. However, revenue and EPS growth are negative at -3.2% and -3.4%, respectively. Valuation metrics include a forward P/E of 18.69 and EV/EBITDA of 13.15, with a dividend yield of 1.9%.
Stock health The stock shows mixed signals: a current ratio of 0.74 and debt/equity of 1.75 suggest leverage concerns, while a Piotroski F-Score of 5/9 and Altman Z of 3.85 indicate moderate financial health. Momentum is positive over 3m (18.32%) but negative over 12m (-10.02%), with RSI(14) at 70.90.
Price vs fair value Unilever trades at a **PREMIUM of 30.80%** to our fair-value estimate of 3450.13 and a **discount of 5.59%** to the 12-month target of 5264.85. - Heatwave boosts ice cream sales, with Magnum beating earnings forecasts (BeInCrypto). - Unilever lifts outlook as McCormick deal and World Cup sponsorship advance (Simply Wall St.). - Guarantees worker pay protections post-McCormick merger (Quartz). - Valuation percentile of 49.4/100 suggests fair valuation (Sideravia).
Looking forward Analysts see potential upside to the 12-month target of 5264.85, driven by strategic initiatives like the McCormick deal and sponsorships. However, revenue declines and leverage ratios warrant caution. Forward P/E of 18.69 and PEG of 0.84 suggest reasonable growth expectations.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.